|
US6818751B1
(en)
|
1997-08-01 |
2004-11-16 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
|
US6630305B1
(en)
|
1999-11-12 |
2003-10-07 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6800746B2
(en)
|
1997-02-25 |
2004-10-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US20030185830A1
(en)
*
|
1997-02-25 |
2003-10-02 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
TR199902053T2
(xx)
|
1997-02-25 |
2000-04-21 |
Corixa Corporation |
Prostat kanserinin immunoterapisine y�nelik bile�ikler ve bunlar�n kullan�lmas�na matuf metodlar.
|
|
US6613872B1
(en)
|
1997-02-25 |
2003-09-02 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
|
US7202342B1
(en)
|
1999-11-12 |
2007-04-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6620922B1
(en)
|
1997-02-25 |
2003-09-16 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6329505B1
(en)
|
1997-02-25 |
2001-12-11 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
|
US6759515B1
(en)
|
1997-02-25 |
2004-07-06 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6943236B2
(en)
|
1997-02-25 |
2005-09-13 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US7517952B1
(en)
|
1997-02-25 |
2009-04-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6894146B1
(en)
|
1997-02-25 |
2005-05-17 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US7270980B2
(en)
*
|
1997-02-25 |
2007-09-18 |
Corixa Corporation |
Compounds for immunodiagnosis of prostate cancer and methods for their use
|
|
US6395278B1
(en)
|
1997-02-25 |
2002-05-28 |
Corixa Corporation |
Prostate specific fusion protein compositions
|
|
US6465611B1
(en)
|
1997-02-25 |
2002-10-15 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
|
US7033827B2
(en)
|
1997-02-25 |
2006-04-25 |
Corixa Corporation |
Prostate-specific polynucleotide compositions
|
|
US6365369B1
(en)
|
1998-04-01 |
2002-04-02 |
Human Genome Sciences, Inc. |
Prostate specific secreted protein
|
|
US6048970A
(en)
*
|
1998-05-22 |
2000-04-11 |
Incyte Pharmaceuticals, Inc. |
Prostate growth-associated membrane proteins
|
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
US20060052321A1
(en)
|
2002-04-05 |
2006-03-09 |
Raitano Arthur B |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
US7037667B1
(en)
|
1998-06-01 |
2006-05-02 |
Agensys, Inc. |
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
|
|
AU757698C
(en)
*
|
1998-06-01 |
2004-04-08 |
Agensys, Inc. |
Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
US20040141975A1
(en)
|
1998-06-01 |
2004-07-22 |
Raitano Arthur B. |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
|
JP2002517185A
(ja)
*
|
1998-06-01 |
2002-06-18 |
アジェンシス，インコーポレイテッド |
前立腺癌および結腸癌の診断および治療に有用な腫瘍抗原
|
|
CN100419079C
(zh)
*
|
1998-07-14 |
2008-09-17 |
科里克萨有限公司 |
用于治疗和诊断前列腺癌的组合物和方法
|
|
EP1117794A2
(en)
*
|
1998-10-02 |
2001-07-25 |
Urogenesys, Inc. |
Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
|
|
US6902892B1
(en)
|
1998-10-19 |
2005-06-07 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
|
EP1724351A3
(en)
*
|
1999-03-11 |
2007-11-14 |
Mount Sinai Hospital |
Human Kallikrein-like genes
|
|
US7022497B1
(en)
*
|
1999-03-11 |
2006-04-04 |
Mt. Sinai Hospital |
Human kallikrein-like genes
|
|
WO2000071711A2
(en)
*
|
1999-05-20 |
2000-11-30 |
Fahri Saatcioglu |
Differentially expressed genes in prostate cancer
|
|
CO5450246A1
(es)
*
|
1999-07-13 |
2004-10-29 |
Smithkline Beecham Corp |
Vacuna
|
|
US6613515B1
(en)
|
1999-09-10 |
2003-09-02 |
Corixa Corporation |
Ovarian tumor sequences and methods of use therefor
|
|
US6617109B1
(en)
|
1999-09-10 |
2003-09-09 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US20030232056A1
(en)
|
1999-09-10 |
2003-12-18 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
AU7129700A
(en)
*
|
1999-09-10 |
2001-04-10 |
Corixa Corporation |
Ovarian tumor sequences and methods of use therefor
|
|
US6710170B2
(en)
|
1999-09-10 |
2004-03-23 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US6720146B2
(en)
|
1999-09-10 |
2004-04-13 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
GB9922835D0
(en)
*
|
1999-09-25 |
1999-11-24 |
Smithkline Beecham Biolog |
Novel compounds
|
|
AU7994200A
(en)
*
|
1999-10-04 |
2001-05-10 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
|
AU7753700A
(en)
*
|
1999-10-07 |
2001-05-10 |
Schering Aktiengesellschaft |
Dna encoding prost 07 polypeptide
|
|
EP1230364A2
(en)
*
|
1999-11-12 |
2002-08-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
IL150732A0
(en)
*
|
2000-01-14 |
2003-02-12 |
Corixa Corp |
Prostate specific polypeptides, polynucleotides that encode said polypeptides and pharmaceutical compositions containing the same
|
|
US7611892B2
(en)
*
|
2000-03-24 |
2009-11-03 |
President And Fellows Of Harvard College |
Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
|
|
CA2403909A1
(en)
*
|
2000-03-27 |
2001-10-04 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
RU2276672C2
(ru)
*
|
2000-04-10 |
2006-05-20 |
Институт Биоорганической химии им. акад. М.М. Шемякина и Ю.А. Овчинникова Российской Академии Наук |
Антитело к фактору hldf, способ его получения (варианты), пептид с антигенными и нк-гидролизующими свойствами и способ диагностики анапластического состояния клетки человека
|
|
WO2001077682A1
(fr)
*
|
2000-04-10 |
2001-10-18 |
Institut Bioorganicheskoi Khimii Imeni Akademikov M.M. Shemyakina I Ju. A. Ovchinnikova Rossiisskoi Akademii Nauk |
Anticorps diriges contre le facteur hldf, procedes de fabrication correspondants, peptides avec des capacites antigeniques et a hydrolyse hk et procede de diagnostic de l'etat anaplasique de cellules humaines
|
|
PT1889630E
(pt)
|
2000-10-18 |
2012-02-29 |
Glaxosmithkline Biolog Sa |
Vacinas compreendendo o antigénio mage ligado a um fragmento da proteína d
|
|
MXPA03004637A
(es)
|
2000-11-28 |
2003-09-05 |
Wyeth Corp |
Analisis de expresion de acidos nucleicos y polipeptidos kiaa utiles en diagnostico y tratamiento de cancer de prostata.
|
|
IL155952A0
(en)
|
2000-11-28 |
2003-12-23 |
Wyeth Corp |
Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
|
ES2537074T3
(es)
|
2001-09-06 |
2015-06-02 |
Agensys, Inc. |
Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer
|
|
US20040162236A1
(en)
*
|
2002-04-01 |
2004-08-19 |
John Alsobrook |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
EP1792912A3
(en)
*
|
2002-04-02 |
2007-08-29 |
Curagen Corporation |
Novel proteins and nucleic acids encoding same
|
|
US20060234227A1
(en)
*
|
2002-05-14 |
2006-10-19 |
Alexei Slesarev |
Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes
|
|
EP1652923B1
(en)
|
2003-08-08 |
2011-10-12 |
Perseus Proteomics Inc. |
Gene overexpressed in cancer
|
|
US7276408B2
(en)
*
|
2003-10-08 |
2007-10-02 |
Texas Instruments Incorporated |
Reduction of dopant loss in a gate structure
|
|
US7335744B2
(en)
*
|
2003-12-23 |
2008-02-26 |
The Regents Of The California University |
Prostate cancer specific internalizing human antibodies
|
|
ES2443996T3
(es)
|
2004-04-22 |
2014-02-21 |
Agensys, Inc. |
Anticuerpos y moléculas derivadas de los mismos que se unen a proteínas STEAP-1
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
PT2468300T
(pt)
|
2006-09-26 |
2018-01-30 |
Infectious Disease Res Inst |
Composição para vacina contendo adjuvante sintético
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
KR20140116546A
(ko)
|
2006-10-27 |
2014-10-02 |
제넨테크, 인크. |
항체 및 면역접합체 및 이들의 용도
|
|
CN102481312B
(zh)
|
2009-06-05 |
2015-07-15 |
传染性疾病研究院 |
合成的吡喃葡萄糖脂佐剂
|
|
US20120263754A1
(en)
|
2011-02-15 |
2012-10-18 |
Immune Design Corp. |
Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines
|
|
WO2012141984A1
(en)
|
2011-04-08 |
2012-10-18 |
Immune Design Corp. |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
|
PL2811981T3
(pl)
|
2012-02-07 |
2019-09-30 |
Infectious Disease Research Institute |
Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania
|
|
KR102136433B1
(ko)
|
2012-05-16 |
2020-07-22 |
이뮨 디자인 코포레이션 |
Hsv-2 백신
|
|
EP2986303B1
(en)
|
2013-04-18 |
2020-02-26 |
Immune Design Corp. |
Gla monotherapy for use in cancer treatment
|
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
|
IL310015B2
(en)
|
2013-12-31 |
2026-02-01 |
Access To Advanced Health Inst |
Single vial formulation
|
|
EP3169352A1
(en)
|
2014-07-15 |
2017-05-24 |
Immune Design Corp. |
Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector
|
|
EP3443123B1
(en)
|
2016-04-11 |
2021-08-11 |
Board of Regents, The University of Texas System |
Methods and compositions for detecting single t cell receptor affinity and sequence
|
|
US11266602B2
(en)
|
2016-05-16 |
2022-03-08 |
Infectious Disease Research Institute |
PEGylated liposomes and methods of use
|
|
DK3458475T3
(da)
|
2016-05-16 |
2022-09-12 |
Access To Advanced Health Inst |
Formulering, der indeholder tlr-agonist, og anvendelsesfremgangsmåder
|
|
AU2017273650B2
(en)
|
2016-06-01 |
2022-08-18 |
Access To Advanced Health Institute |
Nanoalum particles containing a sizing agent
|
|
SG11201909218RA
(en)
|
2017-04-03 |
2019-11-28 |
Hoffmann La Roche |
Antibodies binding to steap-1
|
|
JP2020524143A
(ja)
|
2017-06-15 |
2020-08-13 |
インフェクシャス ディズィーズ リサーチ インスティチュート |
ナノ構造脂質担体、安定エマルジョン、およびその使用
|
|
CA3078223A1
(en)
|
2017-09-08 |
2019-03-14 |
Infectious Disease Research Institute |
Liposomal formulations comprising saponin and methods of use
|
|
EP3976092A1
(en)
|
2019-05-25 |
2022-04-06 |
Infectious Disease Research Institute |
Composition and method for spray drying an adjuvant vaccine emulsion
|
|
CA3173951A1
(en)
|
2020-09-04 |
2022-03-10 |
Emily VOIGT |
Genetically-adjuvanted rna vaccines
|
|
AU2021337493A1
(en)
|
2020-09-04 |
2023-05-18 |
Access To Advanced Health Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
|
CN117120087A
(zh)
|
2020-12-23 |
2023-11-24 |
高级健康研究所 |
茄尼醇疫苗助剂及其制备方法
|